{"pub": "dailymail", "url": "https://thisismoney.co.uk/money/markets/article-7599613/Reckitt-Benckiser-sees-shares-slide-slashes-sales-forecast.html", "downloaded_at": "2019-10-22 13:43:25.858318+00:00", "title": "Reckitt Benckiser sees shares slide as it slashes sales forecast", "language": "en", "text": "Household goods giant Reckitt Benckiser has slashed its annual sales outlook for the second time this year after a 'disappointing' third quarter.\n\nShares in the Durex-to-Vanish group dropped 5 per cent as it said sales fell 0.3 per cent across its health division in the three months to September 30, leaving revenues overall growing by a muted 1.6 per cent to \u00a33.3billion.\n\nReckitt cut its expectations for full-year like-for-like sales growth to between zero and 2 per cent due to the poor third quarter and 'seasonal uncertainty' in the final three months.\n\nDettol maker Reckitt Benckiser has slashed its annual sales outlook\n\nProfit margins are also expected to see a 'modest' fall in 2019, it cautioned.\n\nIt comes after Reckitt lowered its revenue guidance in July amid a slowdown in demand for baby formula in China.\n\nNew chief executive Laxman Narasimhan, who took over from long-serving boss Rakesh Kapoor in September, said: 'Reckitt Benckiser's performance in the third quarter was disappointing.'\n\nHe added: 'This performance is a reflection of an extended period of significant change and disruption in the company.\n\n'I am prioritising execution and operational performance as a matter of urgency.\n\n'I have made it clear within the organisation that any activities that detract focus and attention from improving our operational performance, be paused.'\n\nThe group has been hit by a slowdown in demand for baby formula in China - its biggest market - as birth rates have slowed over the past two years.\n\nIts infant formula business - which took over Mead Johnson Nutrition in 2017 and is part of its health business - saw sales rise 7.2 per cent in the third quarter.\n\nBut Mr Narasimhan said the division continued to face 'challenging' market conditions in China.\n\nThe group's baby formula business was also knocked by supply problems at its European baby formula factory, which left it unable to meet demand at the end of last year, although its supply has since returned to more normal levels.\n\nReckitt also blamed the recent sales woes on cautious retailer demand of its Mucinex and Delsym cold and flu products in the US ahead of the flu season.\n\nOver-the-counter health sales dropped 6.8 per cent on a like-for-like basis in the third quarter as a result, while overall revenues in North America tumbled 12.3 per cent.\n\nMartin Deboo, an analyst at Jefferies, said the figures 'testify to the challenges ahead for the new CEO'.\n\nHe added the path ahead to recovery was set to be 'slow and rocky'.\n\nThe firm also makes a range of over-the-counter drugs like Nurofen\n\nAJ Bell investment director Russ Mould commented; 'Reckitt Benckiser's new CEO Laxman Narasimhan looks like he is taking advantage of the honeymoon period enjoyed by incoming chief executives as he slashes full year sales guidance.\n\n'Kitchen sinking or resetting expectations is a well-rehearsed path in the corporate world although in truth Narasimhan, who joined in September, may have had little choice but to scale back sales expectations after a pretty ropey third quarter.\n\n'Reckitt has been struggling for a while \u2013 evidenced by the fact this is the second downgrade so far in 2019.'", "description": "Shares in the Durex-to-Vanish group dropped 5 per cent as it said sales fell 0.3 per cent across its health division in the three months to September 30, leaving revenues overall muted.", "authors": ["Press Association", "This Is Money", "Some Links In This Article May Be Affiliate Links. If You Click On Them We May Earn A Small Commission. That Helps Us Fund This Is Money", "Keep It Free To Use. We Do Not Write Articles To Promote Products. We Do Not Allow Any Commercial Relationship To Affect Our Editorial Independence."], "top_image": "https://i.dailymail.co.uk/1s/2019/10/22/09/20026858-0-image-a-3_1571733668647.jpg", "published_at": "2019-10-22"}